Effect of subdermal levonorgestrel contraceptive implants, NORPLANT®, on serum lipids

This publication has 14 references indexed in Scilit:

• Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: Relationships to estrogen and progestin potency
  American Journal of Obstetrics and Gynecology, 1982
• A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles
  Contraception, 1981
• Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors
  JAMA, 1979
• ORAL-CONTRACEPTIVE USE IN RELATION TO MYOCARDIAL INFARCTION
  The Lancet, 1979
• SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
  The Lancet, 1978
• NORMAL SERUM-CHOLESTEROL BUT LOW H.D.L.-CHOLESTEROL CONCENTRATION IN YOUNG PATIENTS WITH ISCHÆMIC CEREBROVASCULAR DISEASE
  The Lancet, 1978
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977
• PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
  The Lancet, 1975
• Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs
  BMJ, 1970
• Comparison of Serum Lipid Levels in Patients with Cerebral Thrombosis and in Normal Subjects
  Annals of Internal Medicine, 1963